MAGE qPCR improves the sensitivity and accuracy of EBUS-TBNA for the detection of lymphatic cancer spread

Journal of Thoracic Oncology

Volumn 7, Issue 4, 2012, Pages 690-697

  Cucuruz, Beatrix ^a,b   Dango, Sebastian ^b   Jurinovic, Vindi ^c   Mayer, Olga ^b   Follo, Marie ^b   Böhm, Joachim ^d   Freudenberg, Nikolaus ^d   Elze, Mirjam ^b   Sienel, Wulf ^b   Klein, Christoph A ^a   Passlick, Bernward ^b   Polzer, Bernhard ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d University Hospital Freiburg ^*

Author keywords

Endobronchial ultrasound guided fine needle aspiration (EBUS TBNA); Lymph node metastasis; Mediastinoscopy; Melanoma antigen (MAGE); Non small cell lung cancer (NSCLC)

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOBRONCHIAL ULTRASONOGRAPHY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDIASTINOSCOPY; MELANOMA ANTIGEN A GENE 1; MELANOMA ANTIGEN A GENE 12; MELANOMA ANTIGEN A GENE 2; MELANOMA ANTIGEN A GENE 3; MELANOMA ANTIGEN A GENE 4; MELANOMA ANTIGEN A GENE 5; MELANOMA ANTIGEN A GENE 6; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY ANALYSIS; TRANSBRONCHIAL ASPIRATION; TUMOR GENE;

EID: 84858792195     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31824294de     Document Type: Article

References (42)

1. Crino L, Weder W, van Meerbeeck J, et al. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMOClinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5):v103-v115.
2. D'Addario G, Fruh M, Reck M, et al. Metastatic non-small-cell lung cancer: ESMOClinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5):v116-v119.
3. Lemaire A, Nikolic I, Petersen T, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg 2006;82:1185-1189; discussion 1189-1190.
4. Detterbeck FC, Rivera MP, Socinski M, et al. Diagnosis and Treatment of Lung Cancer: an Evidence-Based Guide for the Practicing Clinician. Philadelphia: Saunders, 2001.
5. Park BJ, Flores R, Downey RJ, et al. Management of major hemorrhage during mediastinoscopy. J Thorac Cardiovasc Surg 2003;126:726-731. (Pubitemid 37151955)
6. Martin LW. Invasive mediastinal staging for non-small-cell lung cancer. Gastrointest Endosc 2008;67:199-201.
7. Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:202S-220S. (Pubitemid 47502808)
8. Andrade RS, Groth SS, Rueth NM, et al. Evaluation of mediastinal lymph nodes with endobronchial ultrasound: the thoracic surgeon's perspective. J Thorac Cardiovasc Surg 2010;139:578-582; discussion 582-583.
9. Herth FJ, Eberhardt R, Vilmann P, et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006;61:795-798. (Pubitemid 44369405)
10. Vincent BD, El-Bayoumi E, Hoffman B, et al. Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration. Ann Thorac Surg 2008;85:224-230. (Pubitemid 350265800)
11. Yasufuku K, Chiyo M, Koh E, et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 2005;50:347-354.
12. Groth SS, Andrade RS. Endobronchial and endoscopic ultrasound-guided fine-needle aspiration: a must for thoracic surgeons. Ann Thorac Surg 2010;89:S2079-S2083.
13. Dango S, Cucuruz B, Mayer O, et al. Detection of disseminated tumour cells in mediastinoscopic lymph node biopsies and endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected lung cancer. Lung Cancer 2010;68:383-388.
14. Wallace MB, Block MI, Gillanders W, et al. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest 2005;127:430-437. (Pubitemid 40229299)
15. Kirkin AF, Dzhandzhugazyan KN, Zeuthen J. Cancer/testis antigens: structural and immunobiological properties. Cancer Invest 2002;20:222-236. (Pubitemid 34205490)
16. Van den Eynde BJ, van der Bruggen P. T cell defined tumor antigens. Curr Opin Immunol 1997;9:684-693. (Pubitemid 27485298)
17. Scanlan MJ, Gure AO, Jungbluth AA, et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002;188:22-32. (Pubitemid 35398862)
18. Mecklenburg I, Weckermann D, Zippelius A, et al. A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer. J Immunol Methods 2007;323:180-193. (Pubitemid 46890967)
19. Sienel W, Mecklenburg I, Dango S, et al. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer. Clin Cancer Res 2007;13:3840-3847. (Pubitemid 47037589)
20. Xi L, Coello MC, Litle VR, et al. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res 2006;12:2484-2491.
21. Gotoh K, Yatabe Y, Sugiura T, et al. Frequency of MAGE-3 gene expression in HLA-A2 positive patients with non-small cell lung cancer. Lung Cancer 1998;20:117-125. (Pubitemid 28346852)
22. Jungbluth AA, Busam KJ, Kolb D, et al. Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 2000;85:460-465. (Pubitemid 30075121)
23. Lucas S, De Smet C, Arden KC, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998;58:743-752. (Pubitemid 28099487)
24. Weynants P, Lethe B, Brasseur F, et al. Expression of mage genes by non-small-cell lung carcinomas. Int J Cancer 1994;56:826-829. (Pubitemid 24102748)
25. Yoshimatsu T, Yoshino I, Ohgami A, et al. Expression of the melanoma antigen-encoding gene in human lung cancer. J Surg Oncol 1998;67:126-129. (Pubitemid 28109979)
26. Park JW, Kwon TK, Kim IH, et al. A new strategy for the diagnosis of MAGE-expressing cancers. J Immunol Methods 2002;266:79-86. (Pubitemid 34804674)
27. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717. (Pubitemid 27260107)
28. Jang SJ, Soria JC, Wang L, et al. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 2001;61: 7959-7963. (Pubitemid 33049388)
29. Kim H, Kim SJ, Lee SH, et al. Usefulness of melanoma antigen (MAGE) gene analysis in tissue samples from percutaneous needle aspiration biopsy of suspected lung cancer lesions. Lung Cancer 2010;69:284-288.
30. Liu F, Killian JK, Yang M, et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 2010;29:3650-3664.
31. Mecklenburg I, Stratakis DF, Huber RM, et al. Detection of melanoma antigen-a expression in sputum and bronchial lavage fluid of patients with lung cancer. Chest 2004;125:164S-166S. (Pubitemid 38648379)
32. dos Santos NR, Torensma R, de Vries TJ, et al. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res 2000;60:1654-1662. (Pubitemid 30183438)
33. Jungbluth AA, Chen YT, Stockert E, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856-860. (Pubitemid 32467376)
34. Fratta E, Sigalotti L, Colizzi F, et al. Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma. J Cell Physiol 2010;223:352-358.
35. Sigalotti L, Fratta E, Coral S, et al. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine. Cancer Res 2004;64:9167-9171. (Pubitemid 39665532)
36. Marcar L, Maclaine NJ, Hupp TR, et al. Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin. Cancer Res 2010;70:10362-10370.
37. Yang B, O'Herrin S, Wu J, et al. Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo. J Invest Dermatol 2007;127:267-275. (Pubitemid 46106901)
38. Yang B, O'Herrin SM, Wu J, et al. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 2007;67:9954-9962. (Pubitemid 47621245)
39. Kemp SV, El Batrawy SH, Harrison RN, et al. Learning curves for endobronchial ultrasound using cusum analysis. Thorax 2010;65:534-538.
40. Navani N, Nankivell M, Nadarajan P, et al. The learning curve for EBUS-TBNA. Thorax 2011;66:352-353.
41. Kubuschok B, Passlick B, Izbicki JR, et al. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 1999;17:19-24. (Pubitemid 29022373)
42. Osaki T, Oyama T, Gu CD, et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. J Clin Oncol 2002;20:2930-2936. (Pubitemid 34728886)